Floreo, Inc. | |
3336 Quesada St Nw, Washington, DC 20015-1665 | |
(240) 244-9473 | |
Not Available |
Full Name | Floreo, Inc. |
---|---|
Type | Facility |
Speciality | Clinic/center - Hearing And Speech |
Location | 3336 Quesada St Nw, Washington, District Of Columbia |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013577279 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Floreo, Inc. 3336 Quesada St Nw, Washington, DC 20015-1665 Ph: (240) 244-9473 | Floreo, Inc. 3336 Quesada St Nw, Washington, DC 20015-1665 Ph: (240) 244-9473 |
News Archive
"India's drug industry — on track to grow about 13 percent this year, to just over $24 billion — was once notorious for making cheap knockoffs of Western medicines and selling them in developing countries. But India, seasoned in the basics of medicine making, is now starting to take on a more mainstream role in the global drug industry, as a result of recent strengthening of patent law here and cost pressures on name-brand drug makers in the West," the New York Times writes.
Certain symptoms associated with the development of Alzheimer's disease, including agitation and depression, affect Hispanics more frequently and severely than other ethnicities.
Ultrasound is widely used to detect breast cancer early, but misdiagnosis of benign lesions as malignant tumors sometimes leads to unnecessary biopsies.
Peregrine Pharmaceuticals has reported that preclinical data presented at the Centennial Annual Meeting of the American Association for Cancer Research (AACR) showed that its monoclonal antibody 2C3, which selectively blocks vascular endothelial growth factor (VEGF) from binding to the second of the two VEGF receptors, demonstrates potent anti-cancer efficacy in a preclinical orthotopic model of pancreatic cancer.
› Verified 5 days ago